123 related articles for article (PubMed ID: 36974822)
21. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
22. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia.
Fernandes D; Barbeiro CO; Palaçon MP; Biancardi MR; Ferrisse TM; Silveira HA; Castilho RM; de Almeida LY; Leon JE; Bufalino A
Immunology; 2023 Jan; 168(1):96-109. PubMed ID: 36056642
[TBL] [Abstract][Full Text] [Related]
23. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
25. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.
Szarka K; Tar I; Fehér E; Gáll T; Kis A; Tóth ED; Boda R; Márton I; Gergely L
Oral Microbiol Immunol; 2009 Aug; 24(4):314-8. PubMed ID: 19572894
[TBL] [Abstract][Full Text] [Related]
26. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
[TBL] [Abstract][Full Text] [Related]
27. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
Liu W; Yao Y; Shi L; Tang G; Wu L
J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
[TBL] [Abstract][Full Text] [Related]
28. Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer.
Webber LP; Wagner VP; Curra M; Vargas PA; Meurer L; Carrard VC; Squarize CH; Castilho RM; Martins MD
Histopathology; 2017 Aug; 71(2):278-286. PubMed ID: 28326594
[TBL] [Abstract][Full Text] [Related]
29. C-kit Expression in Oral Leukoplakia.
Tegginamani AS; Shivakumar VH; Ismail SMB; Abraham MT; Fernandes BA; Zamzuri ATB
J Coll Physicians Surg Pak; 2022 Feb; 32(2):256-258. PubMed ID: 35108805
[TBL] [Abstract][Full Text] [Related]
30. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
31. Differential Expression of EZH2 and H3K27me3 in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia.
Sihavong P; Kitkumthorn N; Srimaneekarn N; Bumalee D; Lapthanasupkul P
Head Neck Pathol; 2021 Jun; 15(2):408-415. PubMed ID: 32720035
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
[TBL] [Abstract][Full Text] [Related]
33. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
34. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma.
de-Assis EM; Pimenta LG; Costa-e-Silva E; Souza PE; Horta MC
Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e733-8. PubMed ID: 22322518
[TBL] [Abstract][Full Text] [Related]
35. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells.
Zheng M; Cao MX; Luo XJ; Li L; Wang K; Wang SS; Wang HF; Tang YJ; Tang YL; Liang XH
J Cell Mol Med; 2019 Oct; 23(10):6942-6954. PubMed ID: 31368152
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
[No Abstract] [Full Text] [Related]
38. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
Zhang D; Ni Z; Xu X; Xiao J
Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
[TBL] [Abstract][Full Text] [Related]
39. Presence of CD3-positive T-cells in oral premalignant leukoplakia indicates prevention of cancer transformation.
Öhman J; Mowjood R; Larsson L; Kovacs A; Magnusson B; Kjeller G; Jontell M; Hasseus B
Anticancer Res; 2015 Jan; 35(1):311-7. PubMed ID: 25550565
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of immunomodulatory mediators in oral precancerous lesions.
Gonçalves AS; Mosconi C; Jaeger F; Wastowski IJ; Aguiar MCF; Silva TA; Ribeiro-Rotta RF; Costa NL; Batista AC
Hum Immunol; 2017 Nov; 78(11-12):752-757. PubMed ID: 28941745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
